PULMATRIX, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PULMATRIX, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $950.00K.
- PULMATRIX, INC. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $53.00K.
- PULMATRIX, INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $1.38M.
- PULMATRIX, INC. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $37.08M.
- PULMATRIX, INC. stock issued during period, value, new issues for fiscal 2023 was $53.00K, a 96.16% decline from fiscal 2022.
- PULMATRIX, INC. stock issued during period, value, new issues for fiscal 2022 was $1.38M, a 96.27% decline from fiscal 2021.
- PULMATRIX, INC. stock issued during period, value, new issues for fiscal 2021 was $37.08M, a 406.96% increase from fiscal 2020.
- PULMATRIX, INC. stock issued during period, value, new issues for fiscal 2020 was $7.31M, a 58.31% decline from fiscal 2019.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $950.00K S-4/A · filed 2026-09-17 | |
| 2023-12-31 | $53.00K 10-K · filed 2025-03-21 | |
| 2023-03-31 | $53.00K 10-Q · filed 2024-11-08 | |
| 2022-12-31 | $1.38M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $1.38M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $37.08M 10-K · filed 2023-03-30 | |
| 2021-03-31 | $37.08M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $7.31M 10-K · filed 2022-03-29 | |
| 2020-06-30 | $7.31M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $17.55M 10-K · filed 2021-03-23 | |
| 2019-06-30 | $14.57M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $2.98M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $19.22M 10-K · filed 2020-03-26 | |
| 2018-06-30 | $14.45M 10-Q · filed 2019-11-01 | |
| 2018-03-31 | $1.85M 10-Q · filed 2019-11-01 | |
| 2017-12-31 | $16.31M 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |